Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Assay Kits Reagents and Instruments Systems

By Technology;

Helicase-Dependent Amplification (HDA), Nicking Enzyme Amplification Reaction (NEAR) , Loop-Mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence Based Amplification (NASBA), Transcription Mediated Amplification (TMA), Single Primer Isothermal Amplification (SPIA), and Others

By Application;

Blood Screening, Infectious Disease Diagnostics, Cancer, and Others

By End-Use;

Hospitals, Diagnostic Laboratories, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn135566212 Published Date: May, 2025 Updated Date: June, 2025

Introduction

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market (USD Million), 2021 - 2031

Isothermal Nucleic Acid Amplification Technology (INAAT) Market was valued at USD 2,713.01 million in the year 2024. The size of this market is expected to increase to USD 5,982.63 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 12.0%.


Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 12.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)12.0 %
Market Size (2024)USD 2,713.01 Million
Market Size (2031)USD 5,982.63 Million
Market ConcentrationLow
Report Pages391
2,713.01
2024
5,982.63
2031

Major Players

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioHelix
  • BioMerieux S.A
  • Hologica
  • New England Biolabs
  • Nugen
  • Qiagen N.V
  • Quidel Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

Fragmented - Highly competitive market without dominant players


The Isothermal Nucleic Acid Amplification Technology (INAAT) Market is witnessing a surge in demand due to the rising need for fast, precise, and affordable diagnostic tools. Unlike conventional PCR, INAAT eliminates thermal cycling, enabling quicker amplification in point-of-care settings. This has made it highly suitable for infectious disease diagnostics, now comprising over 55% of its clinical usage.

Technological Integration Enhancing Usability
Continuous advancements in molecular diagnostics are boosting the adoption of INAAT-based systems. The emergence of automated and portable testing platforms is streamlining diagnostics, especially in decentralized care environments. Nearly 40% of modern molecular diagnostic tools now utilize isothermal methods, indicating a clear shift toward user-friendly, high-speed testing technologies.

Infectious Disease Diagnostics Lead Adoption
INAAT’s capability for early and reliable pathogen detection makes it essential in the fight against infectious diseases. As healthcare strategies shift toward rapid outbreak response, INAAT-based diagnostic kits are gaining preference. More than 60% of rapid diagnostic testing programs now integrate INAAT solutions, reinforcing their central role in public health preparedness.

Expanding Scope Across Diverse Medical Fields
The use of INAAT is expanding into areas such as oncology, genetic screening, and animal health. Its adaptability and low-infrastructure requirements support diagnostics in a range of environments. Currently, over 35% of the market's growth stems from non-infectious applications, underlining its broadening impact in clinical diagnostics.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Application
    4. Market Snapshot, By End-Use
    5. Market Snapshot, By Region
  4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising demand for rapid diagnostics

        2. Increase in infectious disease cases

        3. Advancements in diagnostic technologies

      2. Restraints
        1. High healthcare cost limitations

        2. Strict regulatory compliance issues

        3. Rising tech-based competition threats

      3. Opportunities
        1. Point-of-Care Testing Expansion
        2. Emerging Markets Growth
        3. Strategic Partnerships and Collaborations
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product, 2021 - 2031 (USD Million)
      1. Assay Kits Reagents
      2. Instruments Systems
    2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology, 2021 - 2031 (USD Million)
      1. Helicase-Dependent Amplification (HDA)
      2. Nicking Enzyme Amplification Reaction (NEAR)
      3. Loop-Mediated Isothermal Amplification (LAMP)
      4. Strand Displacement Amplification (SDA)
      5. Nucleic Acid Sequence Based Amplification (NASBA)
      6. Transcription Mediated Amplification (TMA)
      7. Single Primer Isothermal Amplification (SPIA)
      8. Others
    3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application, 2021 - 2031 (USD Million)
      1. Blood Screening
      2. Infectious Disease Diagnostics
      3. Cancer
      4. Others
    4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End-Use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Others
    5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbott Laboratories
      2. Becton, Dickinson and Company
      3. BioHelix
      4. BioMerieux S.A
      5. Hologica
      6. New England Biolabs
      7. Nugen
      8. Qiagen N.V
      9. Quidel Corporation
  7. Analyst Views
  8. Future Outlook of the Market